Status:
NOT_YET_RECRUITING
Clinical and Electrophysiological Patterns of Chronic Dysimmune Polyneuropathy
Lead Sponsor:
Assiut University
Conditions:
Chronic Inflammatory Demyelinating Polyneuropathy
Eligibility:
All Genders
18-80 years
Brief Summary
Chronic dysimmune neuropathies (CDN) are a heterogenous group of acquired inflammatory demyelinating neuropathies including chronic inflammatory demyelinating polyneuropathies (CIDP), Lewis-Sumner Syn...
Detailed Description
CIDP is the most common treatable CDN worldwide. Its prevalence is ranging between approximately 1 to 8.9 cases per 100.000 . In addition, there is often the tendency to diagnose CIDP in order to atte...
Eligibility Criteria
Inclusion
- Age \> 18 years, both sexes, history of sensory and/or motor complaint with progressive course over more 2 months
Exclusion
- \*Patients with systemic diseases (DM, chronic kidney or liver disease, thyroid disease, vitamin B12 deficiency)
- Family history of peripheral neuropathy or neurological symptoms suggestive for heredo-familial neurological disorders
- Patients with infective cause as (HBV, HCV, HIV, leprosy)
- Toxic and drug induced polyneuropathy (chemotherapeutics, antimicrobial ..
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT05219383
Start Date
January 1 2023
End Date
December 1 2026
Last Update
February 2 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.